Stay updated with breaking news from C Diff Infection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A single-center study suggests that FMT and bezlotoxumab ― two recommended therapies for recurrent C difficile infections ― are not commonly used in Spain, which doesn't appear to align with US practice.
Fecal microbiota transplantation did not provide additional benefit in terms of weight loss for patients who underwent bariatric surgery in a randomized placebo-controlled trial.
Freeze-dried, encapsulated fecal microbiota transplantation (FMT) has a safety and effectiveness profile similar to that of liquid colonic FMT, without the procedural risks of colonoscopy.
Building on the success seen with fecal microbiota transplantation, this experimental treatment lowered the rates of recurrent C difficile infections.
When administered to the small, rather than the more commonly used large, intestine, fecal microbiota transplantation results in sustained and better response rates in IBS, according to a new study.